Prominent Mutation of Intron 22 Inversion in Sporadic Hemophilia: Is It Worth the Antenatal Screening?

BACKGROUND: Adequate replacement for patients with hemophilia is costly, especially in countries with limited resources. OBJECTIVE: Factor VIII gene mutations among Thai patients with hemophilia A were analyzed for the most common mutation. The cost-effectiveness of finding one female without family...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasanakul, Werasak, Chuansumrit, Ampaiwan, Sirachainan, Nongnuch, Kadegasem, Praguywan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126152/
https://www.ncbi.nlm.nih.gov/pubmed/35615343
http://dx.doi.org/10.2147/TACG.S363132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126152/
https://www.ncbi.nlm.nih.gov/pubmed/35615343
http://dx.doi.org/10.2147/TACG.S363132

Ejemplares similares